Effect of radiation and tirapazamine (SR-4233) on three melanoma cell lines

Melanoma Research

Volumn 8, Issue 6, 1998, Pages 510-515

  Zhang, M ^a   Stevens, G ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Bioreduction; Cell survival; Hypoxia; Melanoma; Radiosensitivity; SR 4233; Tirapazamine

Indexed keywords

CYTOTOXIC AGENT; TIRAPAZAMINE;

AEROBIC METABOLISM; ARTICLE; CELL SURVIVAL; CYTOTOXICITY; HUMAN; HUMAN CELL; HYPOXIA; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL; RADIOSENSITIVITY; TUMOR CELL;

EID: 0032440195     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199812000-00006     Document Type: Article

References (19)

1. Overgaard J, Horsman MR. Modification of hypoxia-induced radioresistance in tumours by the use of oxygen and sensitizers. Semin Radiat Oncol 1996; 6: 10-21.
2. Brown JM, Giaccia AJ. Tumour hypoxia: the picture has changed in the 1990s. Int J Radiat Biol 1994; 65: 95-102.
3. Stern S, Guichard M. Efficacy of agents counteracting hypoxia in fractionated radiation regimes. Radiother Oncol 1996; 41: 143-149.
4. Baker MA, Zeman EM, Hirst VK, Brown JM. Metabolism of SR 4233 by Chinese hamster ovary cells: basis of selective hypoxic cytotoxicity. Cancer Res 1988; 48: 5947-5952.
5. Koch CJ. Unusual oxygen concentration dependence of toxicity of SR-4233, a hypoxic cell toxin. Cancer Res 1993; 53: 3992-3997.
6. Lartigau E, Guichard M. Does tirapazamine (SR4233) have any cytotoxic or sensitizing effect on three human tumour cell lines at clinically relevant partial oxygen pressure? Int J Radiat Biol 1995; 67: 211-216.
7. Zeman EM, Brown JM, Phil D, Lemmon MJ, Hirst VK, Lee WW. SR 4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells. Int J Radiat Oncol Biol Phys 1986; 12: 1239-1242.
8. Brown JM, Lemmon MJ. Potentiation by the hypoxic cytotoxin SR 4233 of cell killing produced by fractionated irradiation of mouse tumours. Cancer Res 1990; 50: 7745-7749.
9. Biedermann KA, Wang J, Graham RP, Brown JM. SR 4233 cytotoxicity and metabolism in DNA repair-competent and repair-deficient cell cultures. Br J Cancer 1991; 63: 358-362.
10. Brown JM, Siim BG. Hypoxia-specific cytotoxins in cancer therapy. Semin Radiat Oncol 1996; 6: 22-36.
11. Chapman JD. Measurement of tumour hypoxia by invasive and non-invasive procedures: a review of recent clinical studies. Radiother Oncol 1991; suppl 20: 13-19.
12. Coates A, Stevens G, Johnston H. A phase I dose finding study using tirapazamine concurrent with radiotherapy in patients with advanced metastatic melanoma. Clinical Oncological Society of Australasia Annual Scientific Meeting, Brisbane, 1997.
13. Haque AMI, Cera F, Cherubini R, Moschini G, Tiveron P. RABIOLA: a computer program for radiobiological data analysis. Annual Report 1990. National Laboratories of Legnaro, Institute of Nuclear Physics, Report No. 041/91, 1991: 282-283.
14. Höckel M, Sehlenger K, Mitze M, Schffer VI, Vaupel P. Hypoxia and radiation response in human tumours. Semin Radiat Oncol 1996; 6: 3-9.
15. Lartigau E, Ridant AML, Lambin P, Weeger P, Martin L, Sigal R, Lusinchi A, Luboinski B, Eschwege F, Guichard M. Oxygenation of head and neck tumours. Cancer 1993; 71: 2319-2325.
16. Whillans DW, Rauth AM. An experimental and analytical study of oxygen depletion in stirred cell suspensions. Radiat Res 1980; 84: 97-114.
17. McKay MJ, Kefford RF. The spectrum of in vitro radiosensitivity in four human melanoma cell lines is not accounted for by differential induction or rejoining of DNA double strand breaks. Int J Radiat Oncol Biol Phys 1995; 31: 345-352.
18. Bristow RG, Hardy PA, Hill RP. Comparison between in vitro radiosensitivity and in vivo radioresponse of murine tumour cell lines I. Parameters of in vitro radiosensitivity and endogenous cellular glutathione levels. Int J Radiat Oncol Biol Phys 1990; 18: 133-145.
19. Zeman EM, Brown JM. Aerobic radiosensitization by SR 4233 in rodent and human cells: mechanistic and therapeutic implications. Int J Radiat Biol 1991; 59: 117-131.